GSK3B and Parkinson disease: Similarly, IHC was done to further support the findings, and the results showed a significant drop (p < 0.001) in GSK-3β phosphorylation among PD group as compared to the control group while the effect of OLE treatment showed increase in GSK-3β phosphorylation (p < 0.01; Fig. 7A).